Synergy CHC Corp. Common Stock (SNYR) Stock Price

SNYRStock

$0.10−95.13%52W

Market Cap$1.54M

P/E3.41x

PEG Ratio0.02

Div yield—

Beta-4.94

SNYR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-103.99%

Price vs S&P 500 (4W)-42.70%

PEG Ratio0.02

VGM Score49.27

P/E Ratio (Annual)3.41x

Book Value / Share (Quarterly)$0.78

P/TBV (Annual)15.86x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-8.93%

Cash Flow / Share (Quarterly)$-0.34

Price vs S&P 500 (YTD)-107.27%

Gross Margin (TTM)65.37%

Net Profit Margin (TTM)-56.99%

EPS (TTM)$-1.36

10-Day Avg Trading Volume27.56M

EPS Excl Extra (TTM)$-1.36

Revenue Growth (5Y)-2.12%

EPS (Annual)$-1.27

ROI (Annual)-53.28%

Gross Margin (Annual)66.83%

Net Profit Margin (5Y Avg)-9.51%

Cash / Share (Quarterly)$0.03

P/E Basic Excl Extra (TTM)2.81x

Revenue Growth QoQ (YoY)-32.77%

EPS Growth (5Y)118.44%

P/E Normalized (Annual)3.41x

ROA (Last FY)-121.42%

Revenue Growth TTM (YoY)8.35%

EBITD / Share (TTM)$-0.83

ROE (5Y Avg)-100.02%

Operating Margin (TTM)-31.83%

Cash Flow / Share (Annual)$-0.23

P/B Ratio0.27x

P/B Ratio (Quarterly)2.88x

Net Income / Employee (Annual)$-440,800

EV / Revenue (TTM)1.05x

Net Interest Coverage (TTM)-1.06x

ROA (TTM)-110.70%

EPS Growth QoQ (YoY)-88.04%

EV / EBITDA (TTM)3.42x

EPS Incl Extra (Annual)$-1.27

Current Ratio (Annual)1.22x

Quick Ratio (Quarterly)0.24x

3-Month Avg Trading Volume4.97M

52-Week Price Return-95.13%

EV / Free Cash Flow (Annual)5.35x

P/E Incl Extra (TTM)2.81x

Revenue / Employee (TTM)$989,400

Tangible BV / Share (Quarterly)$0.49

P/S Ratio (Annual)0.05x

Asset Turnover (Annual)2.99x

52-Week High$2.96

Operating Margin (5Y Avg)0.32%

EPS Excl Extra (Annual)$-1.27

26-Week Price Return-92.06%

Quick Ratio (Annual)0.73x

13-Week Price Return-62.90%

Total Debt / Equity (Annual)1.91x

Current Ratio (Quarterly)0.93x

Enterprise Value$29.04M

Revenue / Share Growth (5Y)-6.95%

Asset Turnover (TTM)1.94x

Revenue / Employee (Annual)$1,085,000

Inventory Turnover (Annual)3.70x

Pretax Margin (Annual)-40.24%

Cash / Share (Annual)$0.23

3-Month Return Std Dev156.67%

Gross Margin (5Y Avg)68.46%

Net Income / Employee (TTM)$-563,800

EBITDA CAGR (5Y)12.82%

EBITDA Interim CAGR (5Y)-4.00%

ROE (Last FY)-155.15%

Net Interest Coverage (Annual)-1.29x

EPS Basic Excl Extra (Annual)$-1.27

P/FCF (TTM)2.54x

Receivables Turnover (TTM)9.81x

EV / Free Cash Flow (TTM)3.37x

Total Debt / Equity (Quarterly)1.04x

EPS Incl Extra (TTM)$-1.36

Receivables Turnover (Annual)4.71x

ROI (TTM)-31.03%

P/S Ratio (TTM)0.06x

Pretax Margin (5Y Avg)-9.18%

Revenue / Share (Annual)$3.12

Tangible BV / Share (Annual)$0.13

Forward P/E0.60x

Price vs S&P 500 (52W)-113.69%

P/E Ratio (TTM)2.81x

EPS Growth TTM (YoY)-39.32%

Year-to-Date Return-94.45%

5-Day Price Return-1.24%

EPS Normalized (Annual)$-1.27

ROA (5Y Avg)-44.56%

Net Profit Margin (Annual)-40.62%

Month-to-Date Return-41.23%

Cash Flow / Share (TTM)$0.02

EBITD / Share (Annual)$-0.63

Operating Margin (Annual)-20.75%

LT Debt / Equity (Annual)1.42x

ROI (5Y Avg)-61.34%

P/E Excl Extra (TTM)2.81x

LT Debt / Equity (Quarterly)0.04x

EPS Basic Excl Extra (TTM)$-1.36

P/TBV (Quarterly)4.58x

P/B Ratio (Annual)3.85x

Inventory Turnover (TTM)3.35x

Pretax Margin (TTM)-56.57%

Book Value / Share (Annual)$0.53

Price vs S&P 500 (13W)-64.86%

Net Margin Growth (5Y)34.23%

Beta-4.94x

P/FCF (Annual)3.76x

Revenue / Share (TTM)$2.45

ROE (TTM)-71.60%

52-Week Low$0.08

vGradeA

gGradeC

mGradeF

vgmGradeC

SNYR Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q1 2026	May 14, 2026	$0.03	-$0.22	-848.67%(-$0.25)
Q4 2025	Apr 1, 2026	$0.01	-$0.35	-3582.00%(-$0.36)
Q3 2025	Nov 13, 2025	$0.01	$0.01	+0.00%(+$0.00)
Q2 2025	Aug 14, 2025	$0.08	-$0.05	-160.90%(-$0.13)

SNYR Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	Price
SNYRSynergy CHC Corp. Common Stock	A	C	F	$0.10
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	A	$40.98
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	D	$5.50
TRLVTrulieve Cannabis Corp.	B	C	A	$11.82
CRONCronos Group Inc. Common Share	C	B	B	$3.38
GLASGlass House Brands Inc.	C	C	C	$9.88
TLRYTilray Brands, Inc. Common Stock	B	B	D	$4.59
CGCCanopy Growth Corporation Common Shares	B	C	D	$1.00
SNDLSundial Growers Inc. Common Shares	A	C	D	$1.35
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	$3.29
USNAUSANA Health Sciences Inc	B	D	D	$14.04
ACBAurora Cannabis Inc. Common Shares	B	D	C	$4.01
MDWDMediWound Ltd.	C	F	D	$12.66
FTLFFitLife Brands, Inc. Common Stock	B	C	D	$9.79
BTMDBiote Corp. Class A Common Stock	A	D	D	$1.57
NAIINatural Alternatives International Inc.	A	C	D	$2.16
MTEXMannatech Inc.	B	D	B	$6.74
BONBon Natural Life Limited Class A Ordinary Shares	B	D	C	$1.14
AKANAkanda Corp. Common Shares	C	F	D	$3.89
IMCCIM Cannabis Corp. Common Shares	A	B	F	$3.41
MEHAFunctional Brands, Inc. Common Stock	A	C	D	$0.01
TRUUVanEck Utilities TruSector ETF	—	—	C	$23.37

About Synergy CHC Corp. Common Stock

Synergy CHC Corp markets and distributes branded consumer health and wellness products including FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen across multiple distribution channels. The company focuses on health-conscious consumers seeking nutrition, weight management, cognitive health, skincare, and wellness solutions. Flat Tummy operates as a dedicated lifestyle brand targeting women's nutrition and weight management needs.